Clinical Efficacy of Extracorporeal Cardiac Shock Wave Therapy in Patients With Ischemia-reperfusion Injury
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT05624203
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Registry
-
NCT05624203
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT05624203. Randomized; no masking; primary purpose treatment. Start 2022-12-01 (anticipated); primary completion 2024-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Efficacy of Extracorporeal Cardiac Shock Wave Therapy in Patients With Ischemia-reperfusion Injury
- Acronym
- CEECSWIRI
- Condition
- Myocardial Reperfusion Injury
- Condition
- Treatment Outcome
- Condition
- Prognosis
- Condition
- ST Elevation Myocardial Infarction
- Intervention (Device)
- Extracorporeal cardiac shock wave therapy(ECSW)
- Lead sponsor
- First Affiliated Hospital of Kunming Medical University
Record details
- Record id
cardio:ct-nct05624203- Content hash
335bf80463b4b9ce52d4517be930b094fe08b4990f7ad86ee9423461299fc2dd